Celemics, Inc.
주식회사 셀레믹스
Verification summary
- Legal name (EN / KO)
- Celemics, Inc. (주식회사 셀레믹스)
- Business registration no.
119-86-35850(1198635850)- Stock listing
- KOSDAQ listed · stock code
331920· DART01114586 - 12-month KONEPS contracts
7contracts · KRW 970,900,000- Live NTS tax status
- Check live NTS status ↗
- verified_at
How to verify a Korean company (BRN format, live NTS status, DART & KONEPS) →
- English name (as registered with DART)
- Celemics, Inc.
- Korean legal name
- 주식회사 셀레믹스
- Alternate names
- 셀레믹스
- Market
KOSDAQ- Stock Code
331920- DART Corp Code
01114586- CEO
- 박종갑, 김효기
- Business Registration No.
119-86-35850- Corporate Registration No.
1101114481282- Established Date
2010-11-29- Fiscal Month
12- KSIC Industry Code
211- Address (KO)
- 서울특별시 금천구 가산디지털1로 131, A동 19층 및 20층 2004호 외  
- Homepage
- https://www.celemics.com/ ↗
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
2026-11-01 04:33 UTCAnnual Financial Summary (KRW)
2025
Basis CFS (Consolidated)
Currency KRW
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 5,767,635,388 | KRW 6,718,995,008 |
| Operating Income (영업이익) | KRW -3,324,045,675 | KRW -1,903,132,941 |
| Net Income (당기순이익) | KRW -4,036,458,382 | KRW 12,266,469,564 |
| Total Assets (자산총계) | KRW 24,410,576,650 | KRW 29,413,958,613 |
| Total Liabilities (부채총계) | KRW 1,392,236,187 | KRW 2,229,786,896 |
| Total Equity (자본총계) | KRW 23,018,340,463 | KRW 27,184,171,717 |
2026-11-08 02:22 UTCRecent DART Filings (Last 90 Days, up to 20)
| Filed | Theme | Filing (EN) | Filer |
|---|---|---|---|
| No filings in the last 90 days. | |||
Data from Korea's Financial Supervisory Service (OpenDART). FSS does not guarantee accuracy or completeness. Figures as filed, in the currency shown (usually KRW). Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
2026-11-01 04:33 UTCPublic procurement (last 12 months)
Contracts first signed in the last 12 months.
The 12-month window is by original contract signing date: it covers contracts first signed in the period, and excludes amendments registered in the period to contracts signed earlier. Amounts are in KRW from Korea's Public Procurement Service (KONEPS). The 12-month total counts sole contracts in full and joint contracts by the supplier's share; joint contracts without a published share are counted but not summed. Multi-year contracts count only the current-period amount. Unit-price (framework) contracts are reported separately because their values are ceilings, not spend. Where KONEPS reports no total contract amount, the current-period amount is used as the total.
- Aggregation Period
2025-11-08to2026-11-07(basis:original_signed_date)- 12-Month Procurement Amount
- KRW 970,900,000
- 12-Month Contract Count
7(Joint contracts:1)- Unit-Price (Framework) Contracts (Reported Separately)
0contracts | Ceiling: KRW 0
By Procurement Category
| Category | Contracts | 12M Counted Amount (KRW) |
|---|---|---|
| Goods (물품) | 1 | KRW 21,900,000 |
| Construction (공사) | 0 | KRW 0 |
| Services (용역) | 6 | KRW 949,000,000 |
| Foreign Procurement (외자) | 0 | KRW 0 |
By Contract Type
| Contract Type | Contracts | Supplier Share / Current Amount (KRW) | Total Contract Ceiling / Multi-year Total (KRW) |
|---|---|---|---|
| Lump-sum / Standard (총액·일반) | 6 | KRW 970,900,000 | KRW 970,900,000 |
| Multi-year / Continuing (장기·계속비) | 1 | KRW 0 | KRW 1,650,000,000 |
| Unit-price / Framework Ceiling (단가·제3자단가 — excluded from 12M total) | 0 | KRW 0 | KRW 0 |
| Unclassified / Zero-amount (기타) | 0 | KRW 0 | KRW 0 |
Top 5 Government Buyers
| Buyer (Korean Legal Name) | Agency Code | Contracts | 12M Amount (KRW) |
|---|---|---|---|
| 질병관리청 | 1790387 | 4 | KRW 899,000,000 |
| 식품의약품안전처 식품의약품안전평가원 | 1471057 | 1 | KRW 50,000,000 |
| 대한적십자사 혈액수혈연구원 | Z003357 | 1 | KRW 21,900,000 |
| 질병관리청 국립보건연구원 | 1790399 | 1 | KRW 0 |
Recent Contracts (up to 7)
| Signed Date | Contract No. (KONEPS) | Contract Title (KO) | Category / Type | Buyer (KO) | Contract Amount (KRW) | Participation |
|---|---|---|---|---|---|---|
| 2026-10-23 | R26TA02345502 ↗ |
[일반용역,148번][조달,협상,신종]2026년 인플루엔자 및 코로나19 등 전장유전체 서열 정보 생산(2차) | services / lump_sum |
질병관리청 | KRW 144,000,000 | Sole (100%) |
| 2026-08-26 | R26TA02166699 ↗ |
니트로사민 변이원성 평가를 위한 차세대 염기서열 분석(NGS) 연구 | services / lump_sum |
식품의약품안전처 식품의약품안전평가원 | KRW 50,000,000 | Sole (100%) |
| 2026-06-04 | R26TA01923901 ↗ |
Ion Torrent 활용 NGS검사법 연구 관련 시약 구매 계약 | goods / lump_sum |
대한적십자사 혈액수혈연구원 | KRW 21,900,000 | Sole (100%) |
| 2026-05-21 chg 2026-06-01 | R26TA01890117 ↗ |
[연구,150] 수두 바이러스 NGS 기반 전장유전체 분석법 개발 | services / lump_sum |
질병관리청 | KRW 20,000,000 | Sole (100%) |
| 2026-04-30 | R26TA01812985 ↗ |
[학술/장기1차] 혁신형 바이오뱅크 컨소시엄 운영 지원사업(육종암 등 종양성 희귀질환 분야) | services / multi_year |
질병관리청 국립보건연구원 | KRW 450,000,000 | Joint (share N/A) |
| 2025-12-24 | R25TA01254062 ↗ |
[일반용역,8번][조달,협상,신종]2026년 인플루엔자 및 코로나19 전장유전체 생산 | services / lump_sum |
질병관리청 | KRW 588,000,000 | Sole (100%) |
| 2025-12-16 | R25TA01200019 ↗ |
[연구,015] 신경증후군 관련 원인병원체의 NGS 기반 다중검사분석 패널 개발 | services / lump_sum |
질병관리청 | KRW 147,000,000 | Sole (100%) |